I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 6 studies | 19% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 4% | |
| CD4-positive, alpha-beta T cell | 4 studies | 20% ± 3% | |
| epithelial cell | 4 studies | 34% ± 10% | |
| endothelial cell | 4 studies | 24% ± 5% | |
| ciliated cell | 4 studies | 27% ± 5% | |
| pancreatic A cell | 3 studies | 26% ± 5% | |
| B cell | 3 studies | 22% ± 3% | |
| CD8-positive, alpha-beta T cell | 3 studies | 22% ± 3% | |
| conventional dendritic cell | 3 studies | 27% ± 9% | |
| hematopoietic precursor cell | 3 studies | 21% ± 8% | |
| non-classical monocyte | 3 studies | 24% ± 8% | |
| glutamatergic neuron | 3 studies | 22% ± 4% | |
| dendritic cell | 3 studies | 30% ± 12% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 3% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 19% ± 3% |
